Daiwa Securities Group’s Tvardi Therapeutics TVRD Stock Holding History

Daiwa Securities Group’s Portfolio TVRD Stock Details TVRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-5	Closed	–	–	1404
2023 Q3	$0	Hold	5	–	–	﹤0.01%	1343
2023 Q2	$0	Hold	5	–	–	﹤0.01%	1356
2023 Q1	$1K	Hold	5	–	–	﹤0.01%	1288
2022 Q4	$2K	Hold	5	–	–	﹤0.01%	1245
2022 Q3	$2K	Hold	5	–	–	﹤0.01%	1254
2022 Q2	$2K	Hold	5	–	–	﹤0.01%	1261
2022 Q1	$2K	Hold	5	–	–	﹤0.01%	1276
2021 Q4	$2K	Hold	5	–	–	﹤0.01%	1306
2021 Q3	$3K	Buy	5 +2	+67%	+$1K	﹤0.01%	1232
2021 Q2	$1K	Hold	3	–	–	﹤0.01%	1225
2021 Q1	$2K	Hold	3	–	–	﹤0.01%	1167
2020 Q4	$2K	Sell	3 -4	-57%	-$2.1K	﹤0.01%	1143
2020 Q3	$3K	Hold	7	–	–	﹤0.01%	1124
2020 Q2	$3K	Hold	7	–	–	﹤0.01%	1147
2020 Q1	$3K	Hold	7	–	–	﹤0.01%	1146
2019 Q4	$4K	Sell	7 -1	-13%	-$702	﹤0.01%	1136
2019 Q3	$5K	Buy	8 +1	+14%	+$831	﹤0.01%	1078
2019 Q2	$5K	Hold	7	–	–	﹤0.01%	1109
2019 Q1	$5K	Buy	7 +2	+40%	+$1.2K	﹤0.01%	1083
2018 Q4	$2K	Hold	5	–	–	﹤0.01%	1113
2018 Q3	$4K	Hold	5	–	–	﹤0.01%	1094
2018 Q2	$3K	Hold	5	–	–	﹤0.01%	1128
2018 Q1	$2K	Buy	+5	New	+$2.42K	﹤0.01%	1133

Other funds holding TVRD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Daiwa Securities Group's TVRD Position: Q4 2023 in Review

Daiwa Securities Group sold out of Tvardi Therapeutics (TVRD) in Q4 2023, closing a stake of 5 shares.

Daiwa Securities Group first reported a position in TVRD in Q1 2018 and held it in 23 quarters. The position peaked at $5K in Q3 2019. 109 funds tracked by Wall St. Rank hold TVRD as of Q4 2023.

Daiwa Securities Group reported no remaining Tvardi Therapeutics position as of Q4 2023 after selling out during the quarter.
Daiwa Securities Group sold 5 Tvardi Therapeutics shares in Q4 2023.
Daiwa Securities Group first reported a position in Tvardi Therapeutics in Q1 2018 and held it in 23 quarters.
Daiwa Securities Group's Tvardi Therapeutics position peaked at $5K in Q3 2019.
109 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q4 2023.

Based on Daiwa Securities Group's 13F filing for Q4 2023, filed 31 Jan 2024.